220 related articles for article (PubMed ID: 24297995)
21. Ikaros is critical for B cell differentiation and function.
Kirstetter P; Thomas M; Dierich A; Kastner P; Chan S
Eur J Immunol; 2002 Mar; 32(3):720-30. PubMed ID: 11870616
[TBL] [Abstract][Full Text] [Related]
22. Dominant-negative IKAROS enhances IL-3-stimulated signaling in wild-type but not BCR-ABL1(+) mouse BA/F3 cells.
von Palffy S; Bulaeva E; Babovic S; Kannan N; Knapp DJ; Wei L; Eaves CJ; Beer PA
Exp Hematol; 2015 Jul; 43(7):514-23.e1-2. PubMed ID: 25951974
[TBL] [Abstract][Full Text] [Related]
23. Binding of Ikaros to germline Ig heavy chain gamma1 and epsilon promoters.
Ström L; Lundgren M; Severinson E
Mol Immunol; 2003 Mar; 39(13):771-82. PubMed ID: 12617992
[TBL] [Abstract][Full Text] [Related]
24. Bruton's tyrosine kinase and SLP-65 regulate pre-B cell differentiation and the induction of Ig light chain gene rearrangement.
Kersseboom R; Ta VB; Zijlstra AJ; Middendorp S; Jumaa H; van Loo PF; Hendriks RW
J Immunol; 2006 Apr; 176(8):4543-52. PubMed ID: 16585544
[TBL] [Abstract][Full Text] [Related]
25. Stage specific over-expression of the dominant negative Ikaros 6 reveals distinct role of Ikaros throughout human B-cell differentiation.
Tonnelle C; Dijon M; Moreau T; Garulli C; Bardin F; Chabannon C
Mol Immunol; 2009 May; 46(8-9):1736-43. PubMed ID: 19285729
[TBL] [Abstract][Full Text] [Related]
26. Antagonism of B cell enhancer networks by STAT5 drives leukemia and poor patient survival.
Katerndahl CDS; Heltemes-Harris LM; Willette MJL; Henzler CM; Frietze S; Yang R; Schjerven H; Silverstein KAT; Ramsey LB; Hubbard G; Wells AD; Kuiper RP; Scheijen B; van Leeuwen FN; Müschen M; Kornblau SM; Farrar MA
Nat Immunol; 2017 Jun; 18(6):694-704. PubMed ID: 28369050
[TBL] [Abstract][Full Text] [Related]
27. Ikaros cooperates with Notch activation and antagonizes TGFβ signaling to promote pDC development.
Mastio J; Simand C; Cova G; Kastner P; Chan S; Kirstetter P
PLoS Genet; 2018 Jul; 14(7):e1007485. PubMed ID: 30001316
[TBL] [Abstract][Full Text] [Related]
28. Deregulation of Ikaros expression in B-1 cells: New insights in the malignant transformation to chronic lymphocytic leukemia.
Oliveira VC; Lacerda MP; Moraes BBM; Gomes CP; Maricato JT; Souza OF; Schenkman S; Pesquero JB; Moretti NS; Rodrigues CA; Popi AF
J Leukoc Biol; 2019 Sep; 106(3):581-594. PubMed ID: 31299112
[TBL] [Abstract][Full Text] [Related]
29. Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function.
Trageser D; Iacobucci I; Nahar R; Duy C; von Levetzow G; Klemm L; Park E; Schuh W; Gruber T; Herzog S; Kim YM; Hofmann WK; Li A; Storlazzi CT; Jäck HM; Groffen J; Martinelli G; Heisterkamp N; Jumaa H; Müschen M
J Exp Med; 2009 Aug; 206(8):1739-53. PubMed ID: 19620627
[TBL] [Abstract][Full Text] [Related]
30. Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy-chain gene.
Fuxa M; Skok J; Souabni A; Salvagiotto G; Roldan E; Busslinger M
Genes Dev; 2004 Feb; 18(4):411-22. PubMed ID: 15004008
[TBL] [Abstract][Full Text] [Related]
31. E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells.
Lazorchak AS; Schlissel MS; Zhuang Y
Mol Cell Biol; 2006 Feb; 26(3):810-21. PubMed ID: 16428437
[TBL] [Abstract][Full Text] [Related]
32. Induction of sterile transcription from the kappa L chain gene locus in V(D)J recombinase-deficient progenitor B cells.
Grawunder U; Rolink A; Melchers F
Int Immunol; 1995 Dec; 7(12):1915-25. PubMed ID: 8746561
[TBL] [Abstract][Full Text] [Related]
33. IRF8 regulates B-cell lineage specification, commitment, and differentiation.
Wang H; Lee CH; Qi C; Tailor P; Feng J; Abbasi S; Atsumi T; Morse HC
Blood; 2008 Nov; 112(10):4028-38. PubMed ID: 18799728
[TBL] [Abstract][Full Text] [Related]
34. Block in development at the pre-B-II to immature B cell stage in mice without Ig kappa and Ig lambda light chain.
Zou X; Piper TA; Smith JA; Allen ND; Xian J; Brüggemann M
J Immunol; 2003 Feb; 170(3):1354-61. PubMed ID: 12538695
[TBL] [Abstract][Full Text] [Related]
35. Ikaros represses the transcriptional response to Notch signaling in T-cell development.
Kleinmann E; Geimer Le Lay AS; Sellars M; Kastner P; Chan S
Mol Cell Biol; 2008 Dec; 28(24):7465-75. PubMed ID: 18852286
[TBL] [Abstract][Full Text] [Related]
36. A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development.
Shaffer AL; Schlissel MS
J Immunol; 1997 Aug; 159(3):1265-75. PubMed ID: 9233622
[TBL] [Abstract][Full Text] [Related]
37. Ikaros limits follicular B cell activation by regulating B cell receptor signaling pathways.
Heizmann B; Sellars M; Macias-Garcia A; Chan S; Kastner P
Biochem Biophys Res Commun; 2016 Feb; 470(3):714-720. PubMed ID: 26775846
[TBL] [Abstract][Full Text] [Related]
38. Modulation of the IL-7 dose-response threshold during pro-B cell differentiation is dependent on pre-B cell receptor expression.
Marshall AJ; Fleming HE; Wu GE; Paige CJ
J Immunol; 1998 Dec; 161(11):6038-45. PubMed ID: 9834086
[TBL] [Abstract][Full Text] [Related]
39. Active lambda and kappa antibody gene rearrangement in Abelson murine leukemia virus-transformed pre-B cell lines.
Persiani DM; Durdik J; Selsing E
J Exp Med; 1987 Jun; 165(6):1655-74. PubMed ID: 3035056
[TBL] [Abstract][Full Text] [Related]
40. A self-reinforcing regulatory network triggered by limiting IL-7 activates pre-BCR signaling and differentiation.
Ochiai K; Maienschein-Cline M; Mandal M; Triggs JR; Bertolino E; Sciammas R; Dinner AR; Clark MR; Singh H
Nat Immunol; 2012 Jan; 13(3):300-7. PubMed ID: 22267219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
